Combating Inflammation and Fibrosis in Post-Surgery Glaucoma Patients front page preview

Combating Inflammation and Fibrosis in Post-Surgery Glaucoma Patients

Glaucoma is the leading cause of irreversible blindness and post-operative inflammation and fibrosis are determining factors in the failure of 30-50% of drainage surgeries. HyAGlauc is an implantable, biodegradable medic...

pdf 347.9KB

Modifying Macrophages for the Treatment of Inflammatory Diseases front page preview

Modifying Macrophages for the Treatment of Inflammatory Diseases

Macrophages are a sub-type of immune cells that are critical for fighting infection in the body through the release of inflammatory and toxic mediators. However if inflammation persists these Macrophages become destructi...

pdf 306.3KB

Protein Biomarkers for the Prediction of Psychosis. front page preview

Protein Biomarkers for the Prediction of Psychosis.

A blood-based biomarker test for predicting the transition to first episode psychosis in Clinical High Risk (CHR) patients. This blood-based biomarker test can be used alone or in conjunction with clinical data and has s...

pdf 324.6KB

Therapeutic Approach to Restore Haemostasis in Individuals with Haemophilia front page preview

Therapeutic Approach to Restore Haemostasis in Individuals with Haemophilia

A therapeutic approach for the treatment of haemophilia in individuals by restoring their levels of haemostasis through anticoagulant pathways mediated by Activated Protein C (APC).

pdf 498KB

Therapeutic Options for Obesity and Metabolic Syndrome  front page preview

Therapeutic Options for Obesity and Metabolic Syndrome

The development of new therapies for the treatment of obesity attributable to genetic factors. Treatment strategies are available but the side effects associated with their use necessitates the development of new and no...

pdf 388.6KB